Figure 4.
Figure 4. PFS by genomic subgroups (ITT population randomized to ibrutinib). (A) Analysis by IGHV. (B) Analysis by NOTCH1. (C) Analysis by TP53. (D) Analysis by SF3B1. (E) Analysis by BIRC3. (F) Analysis by XPO1.

PFS by genomic subgroups (ITT population randomized to ibrutinib). (A) Analysis by IGHV. (B) Analysis by NOTCH1. (C) Analysis by TP53. (D) Analysis by SF3B1. (E) Analysis by BIRC3. (F) Analysis by XPO1.

Close Modal

or Create an Account

Close Modal
Close Modal